Literature DB >> 17893555

Post-LASIK epithelial dendritic defect associated with Alternaria.

Tolga Kocatürk1, Roberto Pineda, Laura K Green, Dimitri T Azar.   

Abstract

PURPOSE: To report a case of a dendritic epithelial defect with interface inflammation associated with Alternaria sp. after laser in situ keratomileusis (LASIK) surgery.
METHODS: A case report of a 46-year-old woman who presented with a dendritic epithelial defect and interface inflammation after LASIK surgery.
RESULTS: After an apparent post-LASIK herpes simplex keratitis with related interface inflammation failed to respond to medical therapy, cornea culture results were positive for Alternaria fungal sp. 2 weeks and 6 days after presentation. Viral cultures and polymerase chain reaction were negative for herpes simplex virus. Six months after penetrating keratoplasty (and 1 year after LASIK), the patient underwent a cataract extraction OD. Best-corrected visual acuity 18 months after the original LASIK procedure was 20/25 OD.
CONCLUSIONS: Alternaria keratitis may present with a dendritic epithelial defect with interface inflammation mimicking herpes simplex virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893555     DOI: 10.1097/ICO.0b013e31812dfad1

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  3 in total

1.  A rare devastating complication of LASIK: bilateral fungal keratitis.

Authors:  H Taylan Sekeroglu; E Erdem; K Yar; M Yağmur; T R Ersoz; A Uguz
Journal:  J Ophthalmol       Date:  2010-11-11       Impact factor: 1.909

2.  Alternaria keratitis after uneventful phacoemulsification in an otherwise healthy adult.

Authors:  Sana Khochtali; Amir Hriz; Fatma Abid; Imen Khairallah-Ksiaa; Bechir Jelliti; Moncef Khairallah
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-02-16

3.  Clinical characteristics of alternaria keratitis.

Authors:  Ching-Hsi Hsiao; Lung-Kun Yeh; Hung-Chi Chen; Hsin-Chiung Lin; Phil Y F Chen; David H K Ma; Hsin-Yuan Tan
Journal:  J Ophthalmol       Date:  2014-03-20       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.